The traditional pharmaceutical order, once anchored in Western centres, has fundamentally shifted. We now inhabit a bipolar industry landscape dominated by the United States and China. This transformation carries significant implications for patients, investors, and policymakers worldwide. Chinese Pharmaceutical Innovation Drives Global Research Boom China has rapidly closed the gap in medical research. In several key areas, it has now…